Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2 - Wikidata - wikimedia - TriplyDB

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

http://www.wikidata.org/entity/Q27010096

about

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review Contemporary murine models in preclinical astrocytoma drug development Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group.PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.An evaluation of regulatory and commercial barriers to stratified medicine development and adoption.Unbiased estimation for response adaptive clinical trials.A Bayesian response-adaptive trial in tuberculosis: The endTB trial.Optimal Bayesian adaptive trials when treatment efficacy depends on biomarkers.Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma.Recommendations for the design of small population clinical trials

P2860

Q26766584-87323C68-6D83-4A4C-98DA-9D512B625146 Q27026937-8923F218-8F83-43BF-BD3D-1C55B7CC3D22 Q33613942-B81FA587-64F1-4F9A-A43A-C09F777351F0 Q34886822-00AE367E-3609-46C9-911A-5D895E0E02E7 Q37481946-9E9A51B4-4827-46FF-BC32-16C5F896BDBD Q38257149-D12E11AA-E867-41F2-BED4-27DE4B69F20E Q41490570-79FB41AA-0D54-49D0-9CA7-A76F7134E238 Q50170378-60A0933D-FB0E-4674-8BD5-5AD213D362D6 Q50772013-658349F5-A56F-45E7-867A-6754877A8448 Q53370386-16C71D96-7B7C-43AD-AC9D-EFA5977AD853 Q58608361-92583B9A-E427-4F24-93B6-208345C9DE6D

P2860

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

http://www.wikidata.org/entity/Q27010096

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@ast

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@en

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@nl

type

label

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@ast

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@en

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@nl

prefLabel

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@ast

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@en

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@nl

P1433

Q27010096-8069211C-CA05-40E1-A5D3-7B6DEA421B4D

P1476

Q27010096-0013BEF3-E513-48E2-BA72-E847CB5F8D44

P2093

Q27010096-152742CE-D72C-4165-ABCC-64C9C4EF45B6

Q27010096-1551DAE3-1EFB-43FA-A827-03A345E7D4D0

Q27010096-52DC5F17-33FD-4B0D-A68A-7D3D5585CDA1

Q27010096-AA4ACCAD-0C28-44A5-8A70-433F038CC952

Q27010096-BA5F142B-A517-4742-BD3A-945C1899861C

Q27010096-E3E87719-9942-48DE-8416-8B6497570AF6

Q27010096-EC464FDB-C4E1-4CA7-95B3-8C1947A13F41

P2860

Q27010096-05BCAFCA-48EE-416E-894A-36DA37EE99D9

Q27010096-0E38EBBD-28E7-4673-9F08-E60D0CC3C608

Q27010096-1455AD38-E9B1-42CA-BF4B-B775AD8984B1

Q27010096-1EFC293F-3D95-49C6-B980-ACFF1F9A75CF

Q27010096-2597792C-5157-485C-B98E-0AC1DFB7A770

Q27010096-2B3CDD8E-07A7-4B56-A0F5-E33F68D8E508

Q27010096-415561F7-266B-4302-AA16-32F6C33ABA1D

Q27010096-420C525C-1FBA-4011-A8E5-5B3B187D7666

Q27010096-43E22D24-07E4-40D5-8EC8-E1458E810D6B

Q27010096-49EEEBB0-C142-4D55-9AF0-756A4202647B

P304

Q27010096-0DC86A5A-199D-47AB-9B9F-47A030F488CF

P31

Q27010096-95E713B8-9334-4290-A9B8-EF26530E6F1F

P3181

Q27010096-D6BCA89D-E81A-4E8F-BD5C-50AD63B6E0B8

P356

Q27010096-F9B561B0-2519-4E7E-B66F-08978E28663F

P407

Q27010096-BCB7FCBD-5DC5-4220-A198-2A0F734130A9

P433

Q27010096-5D9A2F62-E0BE-4CC4-A46A-179A19FA5188

P478

Q27010096-832F8579-E536-4F28-BB40-24696ED6EEE8

P577

Q27010096-73BAD7D3-12F5-4C92-A0AB-430C23FFB1A7

P5875

Q27010096-4B71EBA8-FA01-42FF-8F40-919ABD96D8FD

P698

Q27010096-92F5A157-06A7-42C5-88C8-120B88249301

P921

Q27010096-26F08710-1917-4F82-9D0B-D86B1A0AA877

P932

Q27010096-B74F006B-7E56-4075-821A-365BD3E656D7

P3181

P356

P1433

P1476

Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2

@en

P2093

B. M. Alexander

http://www.w3.org/2001/XMLSchema#string

D. A. Berry

http://www.w3.org/2001/XMLSchema#string

D. A. Reardon

http://www.w3.org/2001/XMLSchema#string

G. Parmigiani

http://www.w3.org/2001/XMLSchema#string

L. Trippa

http://www.w3.org/2001/XMLSchema#string

P. Y. Wen

http://www.w3.org/2001/XMLSchema#string

W.-K. A. Yung

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

P304

972-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3467122

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/NEUONC/NOT088

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249648643

http://www.w3.org/2001/XMLSchema#string

P698

23857706

http://www.w3.org/2001/XMLSchema#string

P921

P932

3714161

http://www.w3.org/2001/XMLSchema#string